ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibitionKathryn G. Roberts, Charles G. Mullighan, Brian B. Tuch et al.|Blood|2018Cited by 72
Modeling and targeting of erythroleukemia by hematopoietic genome editingIlaria Iacobucci, Charles G. Mullighan, Chunxu Qu et al.|Blood|2021Cited by 43
G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALLIlaria Iacobucci, Charles G. Mullighan, Reiji Fukano et al.|Blood Advances|2022Cited by 3
Multiplex CRISPR/Cas9-Based Genome Editing of Mouse Hematopoietic Stem Cells Recapitulates Acute Erythroid Leukemia and Identifies Therapeutic TargetsIlaria Iacobucci, Charles G. Mullighan, Elena Varotto et al.|Blood|2018Cited by 2